Gene: GLB1L3
Official Full Name: galactosidase beta 1 like 3provided by HGNC
Gene Summary: Predicted to enable beta-galactosidase activity. Predicted to be involved in galactose catabolic process. Predicted to be active in vacuole. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30889 | GLB1L3 Knockout cell line (HEK293) | Human | GLB1L3 | 1:3~1:6 | Negative | Online Inquiry |
GLB1L3 Gene Knockout Cell Lines are sophisticated biological tools designed to facilitate the functional study of the GLB1L3 gene, which has emerged as a significant focus in various research fields including developmental biology, neurobiology, and cancer research. These cell lines have been genetically modified to introduce targeted deletions in the GLB1L3 gene, enabling researchers to directly investigate the gene's role in cellular processes and signaling pathways.
The core functionality of GLB1L3 Gene Knockout Cell Lines revolves around their ability to elucidate gene function by creating a model system where the gene is non-functional. By studying the resulting phenotypic changes, researchers can uncover critical insights into gene interactions, compensation mechanisms, and the downstream effects on cellular behavior. These knockout cells serve as vital instruments for high-throughput screening, drug discovery, and validating targets for therapeutic interventions, thereby enhancing our understanding of disease mechanisms and potential treatments.
In terms of scientific importance, GLB1L3 Gene Knockout Cell Lines are invaluable in both research and clinical applications. They provide a unique platform for investigating genetic contributions to disorders while offering insights that can lead to novel therapeutic strategies. Their use in preclinical studies accelerates the development of targeted gene therapies and personalized medicine approaches, making them indispensable for contemporary biomedical research.
Compared to alternative models, GLB1L3 Gene Knockout Cell Lines stand out due to their precision and reliability. Unlike traditional animal models or transient transfection systems that may yield inconsistent results, these knockout cell lines offer stable, long-term viability, ensuring reproducibility and enhancing the confidence of experimental outcomes.
For researchers, clinicians, and biotechnologists, the value of GLB1L3 Gene Knockout Cell Lines lies in their ability to deepen our comprehension of gene function, disease pathology, and therapeutic potential. By utilizing these cell lines, it opens paths toward ground-breaking discoveries that can eventually translate into significant clinical interventions.
Our company prides itself on its commitment to advancing the field of genetic research through high-quality, meticulously validated biological products. With a focus on innovation and reliability, we continue to support scientific exploration and enable breakthroughs that address unmet medical needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.